PDF herunterladen
Journal of Pediatric Neurology 2016; 14(04): 146-150
DOI: 10.1055/s-0036-1592083
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Evaluation of Children with Subacute Sclerosing Panencephalitis Using Magnetic Resonance Spectroscopy

Berna Kırhan
1   Department of Pediatrics, Harran University Medical Faculty, Sanliurfa, Turkey
,
Mahmut Abuhandan
1   Department of Pediatrics, Harran University Medical Faculty, Sanliurfa, Turkey
,
Hasan Cece
2   Department of Radiology, Harran University Medical Faculty, Sanliurfa, Turkey
,
Mustafa Calik
3   Department of Pediatric Neurology, Harran University Medical Faculty, Sanliurfa, Turkey
,
Abdurrahman Sonmezler
4   Department of Neurology, Harran University Medical Faculty, Sanliurfa, Turkey
,
Nihat Kilicaslan
2   Department of Radiology, Harran University Medical Faculty, Sanliurfa, Turkey
,
Akın İscan
3   Department of Pediatric Neurology, Harran University Medical Faculty, Sanliurfa, Turkey
› Institutsangaben
Weitere Informationen

Publikationsverlauf

18. April 2016

22. Juli 2016

Publikationsdatum:
14. September 2016 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

This study aimed to evaluate metabolite ratios in the brain parenchyma of patients with subacute sclerosing panencephalitis (SSPE) using magnetic resonance spectroscopy (MRS). The study compared 32 children diagnosed with SSPE with a control group of 20 healthy children. Comparisons were made between the study and control groups and between children who had various stages of the disease, as well as between MRS values obtained from the frontal subcortical white matter and parieto-occipital white matter regions by multivoxel MRS imaging. MRS may make a contribution to diagnosis and follow-up of children with SSPE as findings reflecting neuronal loss may be revealed by this imaging technique.

Keywords

SSPE - MRS - clinical stages - children
 

  • References

  • 1 Garg RK. Subacute sclerosing panencephalitis. Postgrad Med J 2002; 78 (916) 63-70
    CrossrefPubMedGoogle Scholar
  • 2 Ayata M, Kimoto T, Hayashi K, Seto T, Murata R, Ogura H. Nucleotide sequences of the matrix protein gene of subacute sclerosing panencephalitis viruses compared with local contemporary isolates from patients with acute measles. Virus Res 1998; 54 (1) 107-115
    CrossrefPubMedGoogle Scholar
  • 3 Risk WS, Haddad FS, Chemali R. Substantial spontaneous long-term improvement in subacute sclerosing panencephalitis. Six cases from the Middle East and a review of the literature. Arch Neurol 1978; 35 (8) 494-502
    CrossrefPubMedGoogle Scholar
  • 4 Salvan AM, Confort-Gouny S, Cozzone PJ, Vion-Dury J, Chabrol B, Mancini J. In vivo cerebral proton MRS in a case of subacute sclerosing panencephalitis. J Neurol Neurosurg Psychiatry 1999; 66 (4) 547-548
    CrossrefPubMedGoogle Scholar
  • 5 Alkan A, Sarac K, Kutlu R , et al. Early- and late-state subacute sclerosing panencephalitis: chemical shift imaging and single-voxel MR spectroscopy. AJNR Am J Neuroradiol 2003; 24 (3) 501-506
    PubMedGoogle Scholar
  • 6 Aydin K, Tatli B, Ozkan M , et al. Quantification of neurometabolites in subacute sclerosing panencephalitis by 1H-MRS. Neurology 2006; 67 (5) 911-913
    CrossrefPubMedGoogle Scholar
  • 7 Buckley EM, Hance D, Pawlowski T , et al. Validation of diffuse correlation spectroscopic measurement of cerebral blood flow using phase-encoded velocity mapping magnetic resonance imaging. J Biomed Opt 2012; 17 (3) 037007
    CrossrefPubMedGoogle Scholar
  • 8 Warren KE. NMR spectroscopy and pediatric brain tumors. Oncologist 2004; 9 (3) 312-318
    CrossrefPubMedGoogle Scholar
  • 9 Bottomley PA, Edelstein WA, Foster TH, Adams WA. In vivo solvent-suppressed localized hydrogen nuclear magnetic resonance spectroscopy: a window to metabolism?. Proc Natl Acad Sci U S A 1985; 82 (7) 2148-2152
    CrossrefPubMedGoogle Scholar
  • 10 Bottomley PA. Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe?. Radiology 1989; 170 (1 Pt 1): 1-15
    CrossrefPubMedGoogle Scholar
  • 11 Lee SK, Kim DW, Kim KK, Chung CK, Song IC, Chang KH. Effect of seizure on hippocampus in mesial temporal lobe epilepsy and neocortical epilepsy: an MRS study. Neuroradiology 2005; 47 (12) 916-923
    CrossrefPubMedGoogle Scholar
  • 12 Alkan A, Kutlu R, Kocak G , et al. Brain MR spectroscopy in children with a history of rheumatic fever with a special emphasis on neuropsychiatric complications. Eur J Radiol 2004; 49 (3) 224-228
    CrossrefPubMedGoogle Scholar
  • 13 Sener RN. Subacute sclerosing panencephalitis findings at MR imaging, diffusion MR imaging, and proton MR spectroscopy. AJNR Am J Neuroradiol 2004; 25 (5) 892-894
    PubMedGoogle Scholar
  • 14 Dyken PR. Subacute sclerosing panencephalitis. Current status. Neurol Clin 1985; 3 (1) 179-196
    CrossrefPubMedGoogle Scholar
  • 15 Zimmerman RA, Wang ZJ. The value of proton MR spectroscopy in pediatric metabolic brain disease. AJNR Am J Neuroradiol 1997; 18 (10) 1872-1879
    PubMedGoogle Scholar
  • 16 Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?. J Neurol 1994; 241 (6) 354-371
    CrossrefPubMedGoogle Scholar
  • 17 Bitsch A, Bruhn H, Vougioukas V , et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999; 20 (9) 1619-1627
    PubMedGoogle Scholar
  • 18 Cecil KM, Jones BV. Magnetic resonance spectroscopy of the pediatric brain. Top Magn Reson Imaging 2001; 12 (6) 435-452
    CrossrefPubMedGoogle Scholar
  • 19 Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994; 10 (4) 191-247
    PubMedGoogle Scholar
  • 20 Tekşam M, Cakir B, Ağildere AM. Proton MR spectroscopy in the diagnosis of early-stage subacute sclerosing panencephalitis. Diagn Interv Radiol 2006; 12 (2) 61-63
    PubMedGoogle Scholar